Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Lifshitz Law Firm, P.C. Announces Investigation of CenterState Bank Corporation (CSFL), resTORbio, Inc. (TORC), Tetraphase Pharmaceuticals, Inc. (TTPH), and The Meet Group, Inc. (MEET)

ACET

NEW YORK, April 30, 2020 (GLOBE NEWSWIRE) --

CenterState Bank Corporation (CSFL)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CSFL to South State Corporation for 0.3001 South State shares per CenterState share.

If you are a CSFL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

resTORbio, Inc. (TORC)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of resTORbio, Inc. (TORC) to Adicet Bio, Inc. ("Adicet"). Under the terms of the agreement, resTORbio will issue a number of shares of resTORbio common stock to Adicet stockholders. Upon closing, shareholders of Adicet will own approximately 75% of the outstanding common stock of resTORbio, while resTORbio shareholders will own only approximately 25%.

If you are a TORC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Tetraphase Pharmaceuticals, Inc. (TTPH)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of of Tetraphase Pharmaceuticals, Inc. (TTPH) to AcelRX Pharmaceuticals, Inc. (“ACRX”). Under the terms of the acquisition agreement, shareholders will receive (i) 0.6303 shares of ACRX common stock for each share of TTPH they own, representing implied per-share merger consideration of $0.96 per share based on ACRX’s April 27, 2020 closing price of $1.42, and (ii) one contingent value right (“CVR”) entitling CVR holders to receive aggregate payments of up to $12.5 million for the achievement of future XERAVA net sales milestones starting in 2021.

If you are a TTPH investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

The Meet Group, Inc. (MEET)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of MEET to NuCom Group for $6.30 per share.

If you are a MEET investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING.© 2020 Lifshitz Law Firm, P.C. The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz Law Firm, P.C.
Phone: 516-493-9780

Facsimile: 516-280-7376
Email: info@jlclasslaw.com